Nanocurcumin improves regulatory T-cell frequency and function in patients with multiple sclerosis

Multiple sclerosis is a chronic incapacitating disease of the central nervous system, it has been reported that the disturbance in the development and function of Treg subpopulations is associated with the disability status in the RRMS. Accordingly, in the current study, the objective was to specify nanocurcumin effects on Treg cells frequency, and function in patients with RRMS.

Source: Journal of Neuroimmunology - January 17, 2019 Category: Allergy & Immunology Authors: Sanam Dolati, Zohreh Babaloo, Hormoz Ayromlou, Majid Ahmadi, Reza Rikhtegar, Davood Rostamzadeh, Leila Roshangar, Mohammad Nouri, Amir Mehdizadeh, Vahid Younesi, Mehdi Yousefi Source Type: research